dbpolt.blogg.se

The latest evidence shows that one dose provides protection as robust as 2 doses.

The HPV vaccination programme is one of the most successful in the world and hasĭramatically lowered the rates of cervical cancer and harmful infections in both women and men – preventing many cancers and saving lives. Under the new advice, all young people will be eligible for one dose as part of the routine adolescent programme.ĭr Vanessa Saliba, Immunisation Consultant Epidemiologist at the UK Health The HPV programme in the UK targets girls and boys aged 12 to 13 and is currently given as a 2-dose course. With recent advice from the World Health Organization’s Scientific Advisory Group for Emergencies (SAGE) committee. The Committee has been considering the potential decision for several years and now considers that there is strong evidence in favour of moving to one dose. The Joint Committee on Vaccination and Immunisation ( JCVI) regularly reviews all vaccination programmes and considers new evidence as it emerges. We are delighted to announce that from 1 September 2023, the universal and gay, bisexual and other men who have sex with men ( GBMSM) human papillomavirus ( HPV) vaccination programmes will change from a 2-dose to a one-dose HPV vaccine schedule for eligible adolescents and GBMSM aged under 25 years. Changes to the HPV vaccination programmes